Table 6 Age-adjusted, Sex-adjusted and eGFR-adjusted logistic regression analysis, odds ratio (OR) with 95% confidence intervals (CI), of 30-day mortality in patients with COVID-19
Age-adjusted | Sex-adjusted | eGFR-adjusted | |||||||
|---|---|---|---|---|---|---|---|---|---|
P-value | OR | 95% CI | P-value | OR | 95% CI | P-value | OR | 95% CI | |
s-Creatinine (µmol/l) | NS | 1.000 | 0.994–1.006 | NS | 1.001 | 0.995–1.007 | - | - | - |
eGFRa (ml/min/1.73m2) | NS | 0.983 | 0.955–1.012 | = 0.010 | 0.969 | 0.946–0.993 | - | - | - |
CRPb (mg/l) | = 0.001 | 1.012 | 1.004–1.019 | < 0.01 | 1.011 | 1.004–1.019 | = 0.001 | 1.011 | 1.004–1.019 |
WBCc count (x10i/l) | < 0.001 | 1.435 | 1.174–1.755 | < 0.001 | 1.464 | 1.190–1.800 | = 0.001 | 1.331 | 1.122–1.579 |
Neutrophil count (x10i/l) | < 0.001 | 1.589 | 1.232–2.015 | < 0.001 | 1.626 | 1.243–2.128 | = 0.000 | 1.613 | 1.237–2.103 |
Lymphocyte count (x10i/l) | NS | 0.498 | 0.126–1.964 | NS | 0.455 | 0.125–1.656 | NS | 0.562 | 0.146–2.157 |
NLRd | = 0.01 | 1.155 | 1.034–1.291 | = 0.01 | 1.151 | 1.033–1.283 | = 0.01 | 1.158 | 1.031–1.301 |
B cell modulation | |||||||||
BAFFe (pg/ml) | < 0.05 | 1.001 | 1.000–1.002 | = 0.01 | 1.001 | 1.000–1.002 | < 0.05 | 1.001 | 1.000–1.002 |
IL-4f (pg/ml) | NS | 1.005 | 0.996–1.014 | NS | 1.003 | 0.995–1.011 | NS | 1.003 | 0.995–1.011 |
IFN- αg (pg/ml) | NS | 1.005 | 0.997–1.014 | NS | 1.003 | 0.995–1.011 | NS | 1.004 | 0.995–1.012 |
T cell modulation | |||||||||
sCD25h/IL-2Rαi (pg/ml) | < 0.05 | 1.000 | 1.000–1.001 | < 0.05 | 1.001 | 1.000–1.001 | NS | 1.000 | 1.000–1.001 |
sCD40L (pg/ml) | NS | 1.000 | 0.999–1.001 | NS | 1.000 | 0.999–1.001 | NS | 1.000 | 1.000–1.001 |
sPD-L1j (pg/ml) | < 0.05 | 1.005 | 1.000–1.009 | < 0.05 | 1.005 | 1.001–1.010 | NS | 1.004 | 0.998–1.009 |
sCD95 (pg/ml) | NS | 1.000 | 1.000–1.000 | NS | 1.000 | 1.000–1.000 | NS | 1.000 | 1.000–1.000 |